MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Low-grade systemic inflammation is often associated with metabolic syndrome, which plays a critical role in the development of the obesity-associated inflammatory diseases, including insulin resistance and atherosclerosis. Here, we investigate how Toll-like receptor–MyD88 signaling in myeloid and endothelial cells coordinately participates in the initiation and progression of high fat diet–induced systemic inflammation and metabolic inflammatory diseases. MyD88 deficiency in myeloid cells inhibits macrophage recruitment to adipose tissue and their switch to an M1-like phenotype. This is accompanied by substantially reduced diet-induced systemic inflammation, insulin resistance, and atherosclerosis. MyD88 deficiency in endothelial cells results in a moderate reduction in diet-induced adipose macrophage infiltration and M1 polarization, selective insulin sensitivity in adipose tissue, and amelioration of spontaneous atherosclerosis. Both in vivo and ex vivo studies suggest that MyD88-dependent GM-CSF production from the endothelial cells might play a critical role in the initiation of obesity-associated inflammation and development of atherosclerosis by priming the monocytes in the adipose and arterial tissues to differentiate into M1-like inflammatory macrophages. Collectively, these results implicate a critical MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 2×
“MyD88 expression was abolished in CD31+ endothelial cells from the (Hirosumi et al., 2002; Zieske et al., 2005; Hotamisligil, 2006; Wärnberg et al., 2006).”
BackgroundAdipose tissue remodeling and obesity
Sun, K., Kusminski, C. M., & Scherer, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45887 · Cited by 1,941
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305 · cited 2×
“…in promoting monocyte differentiation toward M1 proinflammatory macrophages (Verreck et al., 2004; Chitu and Stanley, 2006; Fleetwood et al., 2007; Hamilton, 2008; Kim et al., 2008; Waldo et al., 2008; Brochériou et al., 2011; Chinetti-Gbaguidi and Staels, 2011; Wolfs et al., 2011; Lacey et al.,…”
BackgroundChronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186 · cited 1×
“…Huber et al., 1999; Cheung et al., 2000; Klover et al., 2003; Plomgaard et al., 2005; Hotamisligil, 2006; De Taeye et al., 2007; Dixon and Symmons, 2007; Avouac and Allanore, 2008; Kleemann et al., 2008; Ehses et al., 2009; Ferrante et al., 2009; Monteiro and Azevedo, 2010; Emanuela et al., 2012).”
BackgroundHelical Assembly in the MyD88-IRAK4-IRAK2 Complex in TLR/IL-1R Signalling
Lin, S.-C., Lo, Y.-C., & Wu, H. (2010) · Nature · doi:10.1038/nature09121 · Cited by 1,111 · cited 2×
“Recent investigations have increasingly shown that low-grade systemic inflammation is often associated with metabolic syndrome, which probably plays a critical role in the development of these metabolic diseases”
BackgroundRotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062 · cited 1×
“The cytokines (e.g., IL-1 and IL-6) may feedback on adipocytes to further promote this cross-talk (Rotter et al., 2003; Trujillo et al., 2004; Lagathu et al., 2006; Jager et al., 2007; Stienstra et al., 2010).”
BackgroundSuganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056 · cited 1×
“ATMs are exposed to high local concentrations of FFAs released from adipocytes in obesity, and these serve as important activating ligands for TLR4 and TLR2 signaling in macrophages (Tsujita et al., 1995; Suganami et al., 2005, 2007; Nguyen et al., 2007; Miyazaki et al., 2011; Prieur et al., 2011).”
BackgroundCreely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., & Kumar, S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2006 · Cited by 1,043 · cited 1×
“…(Erridge, 2011), including pathogen-associated molecular patterns, such as ligands for TLRs, endogenous TLR ligands such as fatty acids and inflammatory cytokines, including IL-1 (Shi et al., 2006; Cani et al., 2007; Creely et al., 2007; Cani et al., 2008; Holvoet et al., 2008; Dasu et al., 2012).”
BackgroundNguyen, M. T. A., Favelyukis, S., Nguyen, A.-K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., & Olefsky, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706762200 · Cited by 1,035
Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842 · cited 1×
“We found that the ox-LDL generated by this protocol can consistently activate TLR-induced inflammatory genes and synergize with GM-CSF for up-regulation of M1-associated genes (Hazen et al., 1996; Hamilton et al., 1999; Hazen et al., 1999; Hazen and Heinecke, 1997; Febbraio et al., 2000; Podrez et al., 2000; Zhang et…”
BackgroundSelf-citationLack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748 · cited 2×
“ApoE/ mice, a commonly used model, spontaneously develop atherosclerosis; deficiency in TLR4, IL-1, and IL-1R each reduced vascular inflammation and atherosclerosis in ApoE/ mice (Kirii et al., 2003; Björkbacka et al., 2004; Chi et al., 2004; Michelsen et al., 2004).”
MethodWeight loss and lipolysis promote a dynamic immune response in murine adipose tissue
Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J. F., Lei, J., Zechner, R., & Ferrante, A. W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42845 · Cited by 726 · cited 1×
“Moreover, the conditioned medium from ox-LDL–treated released from enlarged adipocytes and augmented by increased lipolysis in obesity (Landin et al., 1990; Tsujita et al., 1995; Lafontan and Langin, 2009; Kosteli et al., 2010).”
BackgroundAdiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype
Ohashi, K., Parker, J. L., Ouchi, N., Higuchi, A., Vita, J. A., Gokce, N., Pedersen, A. A., Kalthoff, C., Tullin, S., Sams, A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088708 · Cited by 646 · cited 2×
“In obesity, infiltrating M1-like macrophages lead to an overall switch in adipose tissue phenotype, associated with insulin resistance and chronic inflammation (Weisberg et al., 2003; Xu et al., 2003; Lumeng et al., 2007; Zeyda and Stulnig, 2007; Fujisaka et al., 2009; Nguyen et al., 2007; Ohashi et al., 2010; Shaul e…”
BackgroundColony-stimulating factor-1 in immunity and inflammation
Chitu, V., & Stanley, E. R. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.006 · Cited by 635 · cited 1×
“GM-CSF is well-known for its function in promoting monocyte differentiation toward M1 proinflammatory macrophages (Verreck et al., 2004; Chitu and Stanley, 2006; Fleetwood et al., 2007; Hamilton, 2008; Kim et al., 2008; Waldo et al., 2008; Brochériou et al., 2011; Chinetti-Gbaguidi and Staels,…”
BackgroundBjörkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., et al. (2004) · Nature Medicine · doi:10.1038/nm1008 · Cited by 634 · cited 4×
“Indeed, several previous studies using complete MyD88/ mice produced conflicting results regarding the role of MyD88 in obesity-associated inflammatory diseases, which might be due to the immune deficiency of complete MyD88/ mice and the housing environment in different institutions (Björkbacka et al., 2004; Miche…”
BackgroundMethodResultInfluentialFleetwood, A. J., Lawrence, T., Hamilton, J. A., & Cook, A. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5245 · Cited by 607 · cited 1×
“…for its function in promoting monocyte differentiation toward M1 proinflammatory macrophages (Verreck et al., 2004; Chitu and Stanley, 2006; Fleetwood et al., 2007; Hamilton, 2008; Kim et al., 2008; Waldo et al., 2008; Brochériou et al., 2011; Chinetti-Gbaguidi and Staels, 2011; Wolfs et…”
BackgroundChronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488 · cited 1×
“…diet-induced metabolic syndrome and consequent obesity-associated inflammatory diseases (Elhage et al., 1998; Huber et al., 1999; Cheung et al., 2000; Klover et al., 2003; Plomgaard et al., 2005; Hotamisligil, 2006; De Taeye et al., 2007; Dixon and Symmons, 2007; Avouac and Allanore, 2008;…”
BackgroundInflamed fat: what starts the fire?
Neels, J. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27280 · Cited by 463
Prieur, X., Mok, C. Y. L., Velagapudi, V. R., Núñez, V., Fuentes, L., Montaner, D., Ishikawa, K., Camacho, A., Barbarroja, N., O’Rahilly, S., et al. (2011) · Diabetes · doi:10.2337/db10-0705 · Cited by 381 · cited 3×
“In obesity, infiltrating M1-like macrophages lead to an overall switch in adipose tissue phenotype, associated with insulin resistance and chronic inflammation (Weisberg et al., 2003; Xu et al., 2003; Lumeng et al., 2007; Zeyda and Stulnig, 2007; Fujisaka et al., 2009; Nguyen et al., 2007; Ohashi et al., 2010; Shaul e…”
BackgroundKang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R. M., Bergmann, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.004 · Cited by 297 · cited 4×
“To generate myeloid-specific MyD88-deficient mice, we used CD11bCre transgenic mice (generated with the promoter for CD11b, an integrin expressed exclusively in the myeloid lineage; Boillée et al., 2006; Kang et al., 2010; Kang et al., 2012).”
BackgroundMethodInfluentialSelf-citationMacrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity
De Taeye, B. M., Novitskaya, T., McGuinness, O. P., Gleaves, L., Medda, M., Covington, J. W., & Vaughan, D. E. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00194.2007 · Cited by 208
LANDIN, K., LÖNNROTH, P., KROTKIEWSKI, M., HOLM, G., & SMITH, U. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01922.x · Cited by 70
Co-Stimulation of PAFR and CD36 Is Required for oxLDL-Induced Human Macrophages Activation
Rios, F. J. O., Koga, M. M., Ferracini, M., & Jancar, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036632 · Cited by 51 · cited 2×
“Because ox-LDL has been shown to directly act on macrophages in vivo (Nagy et al., 1998; Fischer et al., 2002; Itabe et al., 2011; Rios et al., 2012), we wondered whether it is possible that GM-CSF produced by ox-LDL–activated endothelial cells synergizes with SFAs and ox-LDL to further promote…”
Background
Cited by
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
“33 The MyD88-dependent TLR signaling involves activation of IRAK family of kinases, which in turn stimulate the E3 ubiquitin ligase activity of TRAF6, allowing TRAF6 to undergo self-Liu ubiquitination and to conjugate ubiquitin chains onto other signaling molecules that are involved in the…”
TNF Counterbalances the Emergence of M2 Tumor Macrophages
Kratochvill, F., Neale, G., Haverkamp, J. M., Van de Velde, L.-A., Smith, A. M., Kawauchi, D., McEvoy, J., Roussel, M. F., Dyer, M. A., Qualls, J. E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.033 · Cited by 277
Cre Driver Mice Targeting Macrophages
Shi, J., Hua, L., Harmer, D., Li, P., & Ren, G. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7837-3_24 · Cited by 145
Jiang, S., Maphis, N. M., Binder, J., Chisholm, D., Weston, L., Duran, W., Peterson, C., Zimmerman, A., Mandell, M. A., Jett, S. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109720 · Cited by 92
“Similarly, hTau mice were also crossed to CD11bCre (Itgam Cre ) (Kang et al., 2010) and MyD88 f/f mice (Yu et al., 2014) (a kind gift from Dr. Xiaoxia Li at the Cleveland Clinic Foundation) to generate hTauCD11bCre + MyD88 f/f mice.”
Metadata
- Authors
- Yu, M., Zhou, H., Zhao, J., Xiao, N., Roychowdhury, S., Schmitt, D., Hu, B., Ransohoff, R. M., Harding, C. V., Hise, A. G., Hazen, S. L., DeFranco, A. L., Fox, P. L., Morton, R. E., Dicorleto, P. E., Febbraio, M., Nagy, L. E., Smith, J. D., Wang, J.-A., & Li, X.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2014-04-21
- Volume
- 211
- Issue
- 5
- Pages
- 887-907
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2165628817
- Cited by
- 81
- References
- 25
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.